SCHEMBL24682178

SCHEMBL24682178

COC(=O)c1c(N(Cc2ccccc2)C(C)=O)sc2cc(O)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ PKM P14618 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ TSPO P30536 2/20 0.41
▸ LMNA P02545 3/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ PDK1 Q15118 3/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ CYP1A2 P05177 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ HSP90AA1 P07900 2/20 0.37
▸ TRPV1 Q8NER1 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29800041 1.00 MAPT (0.43) MAPTALDH1A1PKMGAATSPO
SCHEMBL24682174 0.91 TSPO (0.44) TSPOPDK1DYRK1AMEN1KMT2A
SCHEMBL29799804 0.91 TSPO (0.44) TSPOPDK1DYRK1AMEN1KMT2A
SCHEMBL29799959 0.90 ESR1 (0.43) MAPTALDH1A1PKMGAATSPO
SCHEMBL24683189 0.90 ESR1 (0.43) MAPTALDH1A1PKMGAATSPO
SCHEMBL24683154 0.89 LMNA (0.45) MAPTALDH1A1PKMGAATSPO
SCHEMBL29799890 0.89 ESR1 (0.39) MAPTPKMPDK1KDM4EHSP90AA1
SCHEMBL24683210 0.89 ESR1 (0.39) MAPTPKMPDK1KDM4EHSP90AA1
SCHEMBL29800048 0.89 LMNA (0.45) MAPTALDH1A1PKMGAATSPO
SCHEMBL24683885 0.89 MAPT (0.42) MAPTALDH1A1PKMGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed
WO-2022173329-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Акционерное общество "Отисифарм" 2022-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 MAPT 1064/4885ALDH1A1 259/4885PKM 2167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback